In vitro studies have linked calpain to trastuzumab resistance in HER2+ breast cancer cells through generation of a p95HER2 fragment [19, 24], or resistance to chemotherapeutics like doxorubicin through regulating multidrug resistance protein function [25]. This evidence concerns the gene ERBB2 and breast carcinoma.